Faes Farma SA
FFEA
Company Profile
Business description
Faes Farma SA is a pharmaceutical company that specializes in the research, production, distribution, and sale of prescription and generic drugs, over-the-counter medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The company develops new drugs for the treatment of allergy, venous insufficiency, and irritable bowel syndrome. It also provides animal nutrition products. Faes Farma exports its products to more than 60 countries and has operations in Spain, Portugal, Chile, and Mexico, among others.
Contact
Maximo Aguirre, 14
Leioa
Vizcaya48940
ESPT: +34 901120362
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
1,767
Stocks News & Analysis
stocks
16 ASX stocks to buy and hold forever, revisited
This time last year, I highlighted 16 ASX stocks that investors could own indefinitely. One year on, I look at whether there should be any changes to the list of stocks as well as which companies are worth buying now.
stocks
This ASX200 reject could be a contrarian buying opportunity
Johns Lyng’s interim results and index deletion have sent investors running for the exits. Our analyst Esther Holloway thinks the sell-off is overdone.
stocks
A 15 step checklist from Buffett's forgotten inspiration
Phil Fisher achieved remarkable stock market returns by holding high quality growth companies for long periods of time. Here's how he found them.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 7,982.40 | 121.00 | -1.49% |
CAC 40 | 7,941.91 | 105.69 | -1.31% |
DAX 40 | 22,328.77 | 292.18 | -1.29% |
Dow JONES (US) | 41,433.48 | 478.23 | -1.14% |
FTSE 100 | 8,495.99 | 104.23 | -1.21% |
HKSE | 23,721.52 | 60.62 | -0.25% |
NASDAQ | 17,436.10 | 32.22 | -0.18% |
Nikkei 225 | 36,898.83 | 105.72 | 0.29% |
NZX 50 Index | 12,273.83 | 137.14 | -1.10% |
S&P 500 | 5,572.07 | 42.49 | -0.76% |
S&P/ASX 200 | 7,763.40 | 126.70 | -1.61% |
SSE Composite Index | 3,374.08 | 5.75 | -0.17% |